vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and JFrog Ltd (FROG). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $145.3M, roughly 1.9× JFrog Ltd). BALCHEM CORP runs the higher net margin — 14.9% vs -10.5%, a 25.3% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs 8.1%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $33.8M). Over the past eight quarters, JFrog Ltd's revenue compounded faster (20.4% CAGR vs 7.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
BCPC vs FROG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $145.3M |
| Net Profit | $40.3M | $-15.2M |
| Gross Margin | — | 77.9% |
| Operating Margin | 20.5% | -14.7% |
| Net Margin | 14.9% | -10.5% |
| Revenue YoY | 8.1% | 25.2% |
| Net Profit YoY | 8.7% | 34.4% |
| EPS (diluted) | $1.25 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $145.3M | ||
| Q3 25 | $267.6M | $136.9M | ||
| Q2 25 | $255.5M | $127.2M | ||
| Q1 25 | $250.5M | $122.4M | ||
| Q4 24 | $240.0M | $116.1M | ||
| Q3 24 | $239.9M | $109.1M | ||
| Q2 24 | $234.1M | $103.0M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $-15.2M | ||
| Q3 25 | $40.3M | $-16.4M | ||
| Q2 25 | $38.3M | $-21.7M | ||
| Q1 25 | $37.1M | $-18.5M | ||
| Q4 24 | $33.6M | $-23.2M | ||
| Q3 24 | $33.8M | $-22.9M | ||
| Q2 24 | $32.1M | $-14.3M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 77.9% | ||
| Q3 25 | 35.7% | 77.4% | ||
| Q2 25 | 36.4% | 76.3% | ||
| Q1 25 | 35.2% | 75.3% | ||
| Q4 24 | 36.0% | 75.4% | ||
| Q3 24 | 35.6% | 75.0% | ||
| Q2 24 | 35.5% | 78.8% |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -14.7% | ||
| Q3 25 | 20.4% | -15.8% | ||
| Q2 25 | 20.1% | -20.4% | ||
| Q1 25 | 20.4% | -18.8% | ||
| Q4 24 | 19.8% | -21.9% | ||
| Q3 24 | 20.0% | -27.4% | ||
| Q2 24 | 19.6% | -18.6% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | -10.5% | ||
| Q3 25 | 15.1% | -12.0% | ||
| Q2 25 | 15.0% | -17.0% | ||
| Q1 25 | 14.8% | -15.1% | ||
| Q4 24 | 14.0% | -20.0% | ||
| Q3 24 | 14.1% | -21.0% | ||
| Q2 24 | 13.7% | -13.9% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $-0.13 | ||
| Q3 25 | $1.24 | $-0.14 | ||
| Q2 25 | $1.17 | $-0.19 | ||
| Q1 25 | $1.13 | $-0.16 | ||
| Q4 24 | $1.03 | $-0.21 | ||
| Q3 24 | $1.03 | $-0.21 | ||
| Q2 24 | $0.98 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $704.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $887.4M |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $704.4M | ||
| Q3 25 | $65.1M | $651.1M | ||
| Q2 25 | $65.4M | $611.7M | ||
| Q1 25 | $49.9M | $563.5M | ||
| Q4 24 | $49.5M | $522.0M | ||
| Q3 24 | $73.7M | $467.8M | ||
| Q2 24 | $63.7M | $591.3M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $887.4M | ||
| Q3 25 | $1.3B | $859.4M | ||
| Q2 25 | $1.3B | $826.5M | ||
| Q1 25 | $1.2B | $800.0M | ||
| Q4 24 | $1.1B | $773.5M | ||
| Q3 24 | $1.2B | $756.2M | ||
| Q2 24 | $1.1B | $721.4M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.2B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $50.7M |
| Free Cash FlowOCF − Capex | $33.8M | $49.9M |
| FCF MarginFCF / Revenue | 12.5% | 34.3% |
| Capex IntensityCapex / Revenue | 2.3% | 0.6% |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $142.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $50.7M | ||
| Q3 25 | $65.6M | $30.2M | ||
| Q2 25 | $47.3M | $36.1M | ||
| Q1 25 | $36.5M | $28.8M | ||
| Q4 24 | $52.3M | $49.1M | ||
| Q3 24 | $51.3M | $27.6M | ||
| Q2 24 | $45.0M | $16.7M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $49.9M | ||
| Q3 25 | — | $28.8M | ||
| Q2 25 | — | $35.5M | ||
| Q1 25 | — | $28.1M | ||
| Q4 24 | — | $48.5M | ||
| Q3 24 | — | $26.7M | ||
| Q2 24 | — | $16.0M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 34.3% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 27.9% | ||
| Q1 25 | — | 23.0% | ||
| Q4 24 | — | 41.8% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 15.5% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
